WaveMan · Form 4
Bios Equity Partners II, LP insider trades
> Search tickers & screens ⌘K
LIVE

Bios Equity Partners II, LP insider trades

Bios Equity Partners II, LP has filed 4 Form 4s with the SEC that we hold, for In8Bio, INC. (INAB) (10% owner), Cognition Therapeutics INC (CGTX) (Director, 10% owner) and Lantern Pharma Inc. (LTRN) (10% owner). Across all of them we count 3 purchases worth $50.5K and 9 sales worth $676.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 51,608 shares of Lantern Pharma Inc. worth $250.3K, dated 2024-02-28. The first filing on our record is dated 2022-09-29 and the latest 2024-06-11.

In8Bio, INC. (INAB)

10% owner · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-09-28P, purchase reported on Form 43,070$6.2K2022-09-29
2022-09-28P, purchase reported on Form 419,017$38.4K2022-09-29
2022-09-28P, purchase reported on Form 42,913$5.9K2022-09-29

Cognition Therapeutics INC (CGTX)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Lantern Pharma Inc. (LTRN)

10% owner · 1 filing · 9 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-02-27S, sale reported on Form 410,620$46.7K2024-02-29
2024-02-27S, sale reported on Form 44,649$20.5K2024-02-29
2024-02-27S, sale reported on Form 434,731$152.8K2024-02-29
2024-02-28S, sale reported on Form 451,608$250.3K2024-02-29
2024-02-28S, sale reported on Form 46,909$33.5K2024-02-29
2024-02-28S, sale reported on Form 415,780$76.5K2024-02-29
2024-02-29S, sale reported on Form 41,832$8.9K2024-02-29
2024-02-29S, sale reported on Form 413,686$66.7K2024-02-29
2024-02-29S, sale reported on Form 44,185$20.4K2024-02-29
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1813313) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms